Tisotumab vedotin [1418731-10-8]

MedChem Express

Tisotumab vedotin [1418731-10-8]

10

1418731-10-8

Research Use Only

Monoclonal

99.69

Tisotumab vedotin is an antibody drug conjugate (ADC) targeting tissue factor (TF), formed by covalently linking a fully human monoclonal antibody (TF-011) against TF with the microtubule disruptor Monomethyll Auristatin E (MMAE) (HY-15162), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Tisotumab vedotin has immunomodulatory and anti-tumor activities, and can be used in the study of advanced or metastatic solid tumors such as cervical cancer[1][2][3].

-80°C

41116161